# IMMX (Immix Biopharma, Inc.) - SEC EDGAR Financial Statements

> Immix Biopharma, Inc. reported $345.9M in total assets and a net loss of $46.22M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IMMX
- Markdown: https://convexityos.com/fundamentals/IMMX.md
- SEC CIK: 0001873835
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001873835&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$50.10M | Operating profit |
| Net Income | FY 2025 | -$46.22M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.62 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$45.24M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $336.3M | Total debt: $965K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $16.26M | $11.29M | $8.74M | $4.20M | $127K | $248K |
| Total Operating Expenses | $29.96M | $22.67M | $16.14M | $8.22M | $1.35M | $454K |
| **Operating Income** | -$29.96M | -$22.67M | -$16.14M | -$8.22M | -$1.35M | -$454K |
| **EBITDA** | -$29.71M | -$22.64M | -$16.14M | -$8.22M | -$1.35M | -$452K |
| Interest Income | $556K | $1.02M | $572K | -- | -- | -- |
| Interest Expense | -- | -- | -- | $497 | $180K | $102K |
| Income Before Tax | -$29.40M | -$21.66M | -$15.57M | -$8.22M | -$24.38M | -$1.13M |
| Income Tax Expense | $38K | $41K | $26K | $10K | $6.0K | $18K |
| **Net Income** | -$29.40M | -$21.61M | -$15.43M | -$8.23M | -$24.38M | -$1.15M |
| Basic EPS | -$0.89 | -$0.76 | -$0.89 | -$0.59 | -$6.64 | -$0.34 |
| **Diluted EPS** | -$0.89 | -$0.76 | -$0.89 | -$0.59 | -$6.64 | -$0.34 |
| Basic Shares Outstanding | 33.0M | 28.3M | 17.3M | 13.9M | 3.7M | 3.4M |
| Diluted Shares Outstanding | 33.0M | 28.3M | 17.3M | 13.9M | 3.7M | 3.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.54M | $5.33M | $5.98M | $5.73M | $4.58M | $3.97M | $1.98M | $1.37M |
| Total Operating Expenses | $15.95M | $12.46M | $10.80M | $10.89M | $7.66M | $6.72M | $4.68M | $4.99M |
| **Operating Income** | -$15.95M | -$12.46M | -$10.80M | -$10.89M | -$7.66M | -$6.72M | -$4.68M | -$4.99M |
| **EBITDA** | -$15.85M | -$12.37M | -$10.71M | -$10.84M | -$7.57M | -$6.66M | -$4.64M | -$4.97M |
| Interest Income | $2.02M | $914K | $717K | $217K | $85K | $104K | $150K | $186K |
| Income Before Tax | -$13.93M | -$11.54M | -$10.09M | -$10.68M | -$7.58M | -$6.61M | -$4.53M | -$4.80M |
| Income Tax Expense | -- | $14K | -- | $11K | $7.7K | $8.9K | $9.8K | $11K |
| **Net Income** | -$13.93M | -$11.56M | -$10.09M | -$10.65M | -$7.59M | -$6.62M | -$4.54M | -$4.81M |
| Basic EPS | -$0.19 | -$0.18 | -$0.18 | -- | -$0.24 | -$0.22 | -$0.15 | -- |
| **Diluted EPS** | -$0.19 | -$0.18 | -$0.18 | -- | -$0.24 | -$0.22 | -$0.15 | -- |
| Basic Shares Outstanding | 74.1M | 63.8M | 55.4M | -- | 31.9M | 30.0M | 29.7M | -- |
| Diluted Shares Outstanding | 74.1M | 63.8M | 55.4M | -- | 31.9M | 30.0M | 29.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $93.93M | $17.68M | $17.51M | $13.44M | $17.64M | $391K |
| Short-Term Investments | $6.48M | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $100.4M | $17.68M | $17.51M | $13.44M | $17.64M | $391K |
| Other Current Assets | $151K | $32K | $45K | $78K | -- | -- |
| **Total Current Assets** | $101.2M | $20.20M | $19.79M | $14.90M | $18.19M | $532K |
| Property, Plant & Equipment, Net | $2.52M | $1.74M | $50K | $3.6K | $5.7K | $7.4K |
| Other Non-Current Assets | $20K | $20K | -- | $6.7K | -- | -- |
| **Total Non-Current Assets** | $3.60M | $2.75M | $137K | $10K | $5.7K | $7.4K |
| **Total Assets** | $104.8M | $22.95M | $19.93M | $14.91M | $18.19M | $540K |
| Accounts Payable | $5.44M | $5.39M | $1.43M | $143K | -- | -- |
| **Total Current Liabilities** | $10.11M | $8.69M | $3.72M | $1.27M | $202K | $5.27M |
| **Total Non-Current Liabilities** | $934K | $1.01M | $0 | $475K | $0 | $0 |
| **Total Liabilities** | $11.04M | $9.70M | $3.72M | $1.75M | $202K | $5.27M |
| **Total Debt (incl. Leases)** | $1.07M | $1.07M | -- | -- | -- | -- |
| Common Stock | $5.3K | $2.8K | $2.0K | $1.4K | $1.3K | $338 |
| Retained Earnings | -$104.5M | -$75.02M | -$53.41M | -$37.99M | -$29.76M | -$5.37M |
| Accumulated Other Comp. Income | $60K | -$1.1K | $135K | $87K | $125K | $132K |
| **Total Stockholders' Equity** | $93.80M | $13.25M | $16.41M | $13.16M | $17.99M | -$4.73M |
| Total Equity | $93.80M | $13.25M | $16.20M | $13.16M | $17.99M | -$4.73M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $320.3M | $225.5M | $79.25M | $93.93M | $15.95M | $11.64M | $15.92M | $17.68M |
| Short-Term Investments | $15.99M | $6.62M | $11.33M | $6.48M | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $336.3M | $232.1M | $90.60M | $100.4M | $15.95M | $11.64M | $15.92M | $17.68M |
| Other Current Assets | $115K | $279K | $336K | $151K | $133K | $138K | $168K | $32K |
| **Total Current Assets** | $338.1M | $233.8M | $92.27M | $101.2M | $16.58M | $12.33M | $16.78M | $20.20M |
| Property, Plant & Equipment, Net | $2.41M | $2.36M | $2.43M | $2.52M | $2.36M | $2.23M | $2.12M | $1.74M |
| Long-Term Investments | $4.57M | $2.05M | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $20K | $20K | $20K | $20K | $20K | $20K | $20K | $20K |
| **Total Non-Current Assets** | $7.87M | $5.32M | $3.54M | $3.60M | $3.50M | $3.31M | $3.11M | $2.75M |
| **Total Assets** | $345.9M | $239.1M | $95.82M | $104.8M | $20.08M | $15.64M | $19.89M | $22.95M |
| Accounts Payable | $5.60M | $5.28M | $4.73M | $5.44M | $7.05M | $6.61M | $5.74M | $5.39M |
| **Total Current Liabilities** | $10.03M | $9.30M | $10.54M | $10.11M | $10.85M | $10.01M | $9.31M | $8.69M |
| **Total Non-Current Liabilities** | $869K | $891K | $912K | $934K | $965K | $972K | $991K | $1.01M |
| **Total Liabilities** | $10.89M | $10.19M | $11.45M | $11.04M | $11.82M | $10.98M | $10.30M | $9.70M |
| **Total Debt (incl. Leases)** | $965K | $1.00M | $1.04M | $1.07M | $1.11M | $1.04M | $1.06M | $1.07M |
| Common Stock | $8.4K | $7.2K | $5.3K | $5.3K | $3.3K | $2.8K | $2.8K | $2.8K |
| Retained Earnings | -$140.0M | -$126.1M | -$114.5M | -$104.5M | -$93.78M | -$86.19M | -$79.57M | -$75.02M |
| Accumulated Other Comp. Income | $6.4K | $119K | $106K | $60K | $62K | $65K | $15K | -$1.1K |
| **Total Stockholders' Equity** | $335.1M | $228.9M | $84.36M | $93.80M | $8.26M | $4.65M | $9.59M | $13.25M |
| Total Equity | $335.1M | $228.9M | $84.36M | $93.80M | $8.26M | $4.65M | $9.59M | $13.25M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$29.44M | -$21.70M | -$15.60M | -$8.23M | -$24.38M | -$1.15M |
| Depreciation & Amortization | $246K | $33K | $5.5K | $2.1K | $2.5K | $2.3K |
| Stock-Based Compensation | $2.44M | $3.02M | $2.57M | $624K | $219K | -- |
| **Operating Cash Flow** | -$23.93M | -$14.60M | -$11.37M | -$7.41M | -$1.59M | -$405K |
| Capital Expenditure | -$733K | -$1.18M | -$52K | -- | -$802 | -- |
| **Free Cash Flow** | -$24.66M | -$15.77M | -$11.42M | -- | -$1.59M | -- |
| **Investing Cash Flow** | -$7.21M | -$1.18M | -$52K | -- | -$802 | -- |
| Common Stock Issued | $107.4M | $15.95M | $15.52M | $2.91M | $18.65M | -- |
| Share Repurchases | -- | -- | -- | -$100K | -- | -- |
| **Financing Cash Flow** | $107.4M | $15.95M | $15.46M | $3.23M | $18.85M | -- |
| **Net Change in Cash** | $76.25M | $172K | $4.07M | -$4.21M | $17.25M | -$343K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.93M | -$11.56M | -$10.10M | -$10.69M | -$7.59M | -$6.62M | -$4.54M | -$4.81M |
| Depreciation & Amortization | $94K | $91K | $92K | $52K | $97K | $58K | $38K | $21K |
| Stock-Based Compensation | $1.29M | $978K | $576K | $571K | $470K | $532K | $868K | $706K |
| **Operating Cash Flow** | -$12.31M | -$11.74M | -$9.83M | -$11.03M | -$5.91M | -$5.31M | -$1.69M | -$1.48M |
| Capital Expenditure | -$121K | -$21K | -$32K | -$165K | -$372K | -$128K | -$68K | -$507K |
| **Free Cash Flow** | -$12.43M | -$11.76M | -$9.86M | -$11.19M | -$6.28M | -$5.44M | -$1.75M | -$1.98M |
| **Investing Cash Flow** | -$12.03M | $2.67M | -$4.80M | -$6.65M | -$372K | -$128K | -$68K | -$507K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $119.2M | $155.3M | -$38K | -- | -- | -- | -- | $0 |
| **Net Change in Cash** | $94.82M | $146.2M | -$14.68M | $77.98M | $4.31M | -$4.28M | -$1.76M | -$2.01M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -31.3% | -163.1% | -94.0% | -62.5% | -135.5% | -- |
| Return on Assets (ROA) | -28.0% | -94.2% | -77.4% | -55.2% | -134.0% | -212.7% |
| Current Ratio | 10.01x | 2.33x | 5.32x | 11.70x | 90.01x | 0.10x |
| Quick Ratio | 9.93x | 2.04x | 4.70x | 10.55x | 87.33x | 0.07x |
| Debt to Equity | 0.01x | 0.08x | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -13.8% | -17.4% | -41.4% | -31.3% | -285.1% | -497.0% | -217.8% | -163.1% |
| Return on Assets (ROA) | -13.4% | -16.7% | -36.5% | -28.0% | -117.3% | -147.9% | -105.1% | -94.2% |
| Current Ratio | 33.72x | 25.13x | 8.76x | 10.01x | 1.53x | 1.23x | 1.80x | 2.33x |
| Quick Ratio | 33.55x | 24.95x | 8.60x | 9.93x | 1.47x | 1.16x | 1.71x | 2.04x |
| Debt to Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.13x | 0.22x | 0.11x | 0.08x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
